Countries using and planning
to introduce IPV
1|
Countries using and planning to introduce IPV
June 2015 status report
This slide deck provides a summary per country on the status of planning for the
introduction of Inactivated Poliomyelitis Vaccine (IPV).
Information here is updated monthly based on information shared by WHO and UNICEF Regional
Offices. Please contact [email protected] with any questions or updates on this data.
Definitions
 Formal decision to introduce: The country has documentation of its decision to introduce
IPV which has been verified by the relevant WHO Regional Office, or for GAVI eligible
countries, a complete application for IPV has been submitted to the GAVI Secretariat.
 Intent to introduce: The country has informally indicated that it plans to introduce IPV, e.g.
planning an application to GAVI, or by requesting technical assistance to develop an IPV
introduction plan.
Tracking these decisions and informal intents provide an indication of the global trend towards
meeting the targets of the Polio Eradication and Endgame Strategic Plan.
2|
Countries using IPV vaccine to date
and formal decision/intent to introduce
Introduced* to date
Formal commitment to
introduce in 2015
(89 countries or 46%)
(91 countries or 47%)
(4 countries or 2%)
Intend to introduce in 2015
(Cook Islands, Fiji, Mauritius, Thailand)
Formal commitment to introduce in 2016 (10 countries or 5%)
Not Available / Not introduced / No Plans
Since January 2013, the following countries have introduced IPV: Kazakhstan
& Peru (July 2013); Libya (March 2014); Albania (May 2014); Panama (July
2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China
(December 2014); Comoros, Senegal & Serbia (January 2015); Colombia &
Nigeria (February 2015); Bangladesh & Maldives (March 2015); DPR Korea,
DR Congo & Gambia (April 2015); Madagascar & Sudan (May 2015)
Not applicable
* Includes introductions in some parts of the country only
3|
Date of slide: 1 June 2015
The boundaries and names shown and the designations used on this map do not imply
the expression of any opinion whatsoever on the part of the World Health Organization
concerning the legal status of any country, territory, city or area or of its authorities, or
concerning the delimitation of its frontiers or boundaries. Dotted lines on maps
represent approximate border lines for which there may not yet be full agreement.
©WHO 2015. All rights reserved.
Data source: WHO/IVB Database, as of 01 June 2015
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
Countries using IPV vaccine to date and introductions
planned according to Gavi eligibility status
Introduced* to date
(89 countries or 46%)
Gavi countries with formal commitment
to introduce in 2015-16
(62 countries or 32%)
Non Gavi countries with formal
commitment to introduce in 2015-16 (39 countries or 20.1%)
Non Gavi countries with intent to introduce in 2015
(Cook Islands, Fiji, Mauritius, Thailand)
Not Available / Not introduced / No Plans
Not applicable
4|
(4 countries or 2%)
Since January 2013, the following countries have introduced IPV: Kazakhstan
& Peru (July 2013); Libya (March 2014); Albania (May 2014); Panama (July
2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China
(December 2014); Comoros, Senegal & Serbia (January 2015); Colombia &
Nigeria (February 2015); Bangladesh & Maldives (March 2015); DPR Korea,
DR Congo & Gambia (April 2015);Madagascar & Sudan (May 2015)
* Includes introductions in some parts of the country only
Date of slide: 1 June 2015
The boundaries and names shown and the designations used on this map do not imply
the expression of any opinion whatsoever on the part of the World Health Organization
concerning the legal status of any country, territory, city or area or of its authorities, or
concerning the delimitation of its frontiers or boundaries. Dotted lines on maps
represent approximate border lines for which there may not yet be full agreement.
©WHO 2015. All rights reserved.
Data source: WHO/IVB Database, as of 01 June 2015
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
105 countries introducing IPV between June
2015 and January 2016
Jun-15
Botswana
Cameroon
Chad
Cote d'Ivoire
Grenada
Kiribati
Lesotho
Morocco
Nauru
Niger
St Vincent & the
Grenadines
Tuvalu
Jul-15
Azerbaijan
Bahamas
Bhutan
Cabo Verde
Chile
Pakistan
Sri Lanka
12
Aug-15
Argentina
Guinea
Iraq
Namibia
Papua New Guinea
Macedonia
7
6
Sep-15
Afghanistan
Benin
Central African Rep.
Djibouti
Dominican Rep.
Gabon
Guinea-Bissau
Guyana
Iran (Islamic Rep. of)
Jamaica
Oct-15
Antigua & Barbuda
Armenia
Belize
Bolivia
Cambodia
Congo
Cook Islands
Cuba
Equatorial Guinea
Ethiopia
Mozambique
Seychelles
Solomon Islands
South Sudan
Swaziland
Timor-Leste
Togo
Trinidad & Tobago
Vanuatu
Fiji
Honduras
India
Kenya
Lao PDR
Mali
Mauritania
Mongolia
Myanmar
Nicaragua
Rep. of Moldova
Saint Kitts & Nevis
Saint Lucia
Samoa
Sao Tome & Principe
Somalia
Tajikistan
Tonga
Uganda
United Rep. of Tanzania
Uzbekistan
Zimbabwe
19
Nov-15
Algeria
Barbados
Burundi
Dominica
Eritrea
Haiti
Indonesia
Suriname
Turkmenistan
5|
Tier 2 countries
Jan-16
Angola
Burkina Faso
Egypt
Ghana
Liberia
Malawi
Rwanda
Sierra Leone
Viet Nam
Zambia
Yemen and Mauritius
are introducing in 2015
but no month of
introduction available.
32
Legend
Tier 1 countries
Dec-15
Ecuador
El Salvador
Georgia
Guatemala
Kyrgyzstan
Paraguay
Thailand
Venezuela
Intent to introduce
Tier 1 countries are countries with cVDPV2 transmission or cVDPV2 reported since 2000 & WPV endemic
countries
Tier 2 countries are countries with cVDPV 1/3 since 2000 or large /medium size countries with DTP3
coverage <80% in the past 3 years as per WUENIC
9
8
10
Source: WHO/UNICEF
database as at 01 June 2015
Tier 1 and 2 Countries using IPV vaccine to date
and formal decision to introduce
Introduction* to date
(5 countries or 14%)
Formal commitment to introduce in 2015
(30 countries or 86%)
Since January 2013, the following Tier 1 and 2 countries have introduced IPV:
The Philippines (October 2014), China (December 2014) and Nigeria
(February 2015); DR Congo (April 2015); Madagascar (May 2015)
Not applicable or not Tier 1 or 2 countries
Tier 1 countries are countries with cVDPV2 transmission or cVDPV2 reported since 2000 & WPV endemic countries
Tier 2 countries are countries with cVDPV 1/3 since 2000 or large /Medium size countries
with DTP3 coverage <80% in the past 3 years as per WUENIC
* Includes introductions in some parts of the country only
6|
Date of slide: 1 June 2015
The boundaries and names shown and the designations used on this map do not imply
the expression of any opinion whatsoever on the part of the World Health Organization
concerning the legal status of any country, territory, city or area or of its authorities, or
concerning the delimitation of its frontiers or boundaries. Dotted lines on maps
represent approximate border lines for which there may not yet be full agreement.
©WHO 2015. All rights reserved.
Data source: WHO/IVB Database, as of 01 June 2015,
based on 35 tier 1 & 2 countries
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
Middle Income Countries using IPV vaccine to date
and formal/intent decision to introduce
Introduced* to date
Formal commitment to
introduce in 2015
(33 countries or 17%)
(59 countries or 30%)
Intend to introduce in 2015
(3 countries or 1.5%)
(Fiji, Mauritius, Thailand)
(5 countries or 2.5%)
Formal commitment to introduce in 2016
(Angola, Egypt, Ghana, Viet Nam, Zambia)
Not applicable / Not Middle Income Countries
Since January 2013, the following MIC have introduced IPV:
Kazakhstan (July 2013); Peru (July 2013); Libya (March 2014); Albania (May
2014); Panama (July 2014); Tunisia (September 2014); Philippines (October
2014); China (December 2014); Senegal (January 2015); Serbia (January 2015);
Colombia (February 2015); Maldives (March 2015) and Sudan (May 2015)
* Includes introductions in some parts of the country only
7|
Date of slide: 1 June 2015
The boundaries and names shown and the designations used on this map do not imply
the expression of any opinion whatsoever on the part of the World Health Organization
concerning the legal status of any country, territory, city or area or of its authorities, or
concerning the delimitation of its frontiers or boundaries. Dotted lines on maps
represent approximate border lines for which there may not yet be full agreement.
©WHO 2015. All rights reserved.
Data source: WHO/IVB Database, as of 01 June 2015 based on 100
middle income countries (MIC) as per last World Bank classification
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
IPV introduction status and planned introduction
by quarter by the end of 2015
Introduced* to date
(89 countries or 46%)
Introduction planned in June 2015
(12 countries or 6%)
Introduction planned in Q3 2015
(32 countries or 16%)
Introduction planned in Q4 2015
(49 countries or 25%)
Introduction planned in 2016
(12 countries or 6%)
or planned in 2015 but month of introduction
not known
Since January 2013, the following countries have introduced IPV: Kazakhstan
& Peru (July 2013); Libya (March 2014); Albania (May 2014); Panama (July
2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China
(December 2014); Comoros, Senegal & Serbia (January 2015); Colombia &
Nigeria (February 2015); Bangladesh & Maldives (March 2015); DPR Korea,
DR Congo & Gambia (April 2015);Madagascar & Sudan (May 2015)
Not applicable
Not available
8|
* Includes introductions in some parts of the country only
Date of slide: 1 June 2015
The boundaries and names shown and the designations used on this map do not imply
the expression of any opinion whatsoever on the part of the World Health Organization
concerning the legal status of any country, territory, city or area or of its authorities, or
concerning the delimitation of its frontiers or boundaries. Dotted lines on maps
represent approximate border lines for which there may not yet be full agreement.
©WHO 2015. All rights reserved.
Data source: WHO/IVB Database, as of 01 June 2015
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization